Trial Profile
The effectiveness of duloxetine compared with placebo in the treatment of predominant stress urinary incontinence
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Aug 2006
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary)
- Indications Stress incontinence
- Focus Registrational; Therapeutic Use
- 03 Aug 2006 Status change
- 30 Oct 2005 New trial record.